lentiviral vector based gene therapy (Scripps Research Institute/City of Hope)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namelentiviral vector based gene therapy (Scripps Research Institute/City of Hope)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vectorBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionT-cell surface antigen CD4 inhibitors
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCity of HopeThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A